Frequently Asked Questions
Updated by our Medical Advisory Panel March 2023
Similar Posts
IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency
8 May 2012 This statement is intended to provide a summary of IPOPI’s position with regards to the importance of ensuring access for patients living with a primary immunodeficiency (PID) to the best suited immunoglobulin (IG) replacement therapy, as selected and prescribed by their physician. IPOPI is concerned by recent developments in several countries that…